GSA Capital Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-37,089
Closed -$715K 1872
2023
Q4
$715K Buy
+37,089
New +$672K 0.06% 579
2021
Q4
Sell
-15,036
Closed -$470K 1684
2021
Q3
$470K Buy
+15,036
New +$592K 0.05% 733
2021
Q1
Sell
-11,284
Closed -$305K 1375
2020
Q4
$305K Buy
+11,284
New +$290K 0.05% 722
2020
Q1
Sell
-19,358
Closed -$100K 1416
2019
Q4
$100K Buy
19,358
+3,829
+25% +$24.6K 0.01% 1344
2019
Q3
$90K Sell
15,529
-52,550
-77% -$236K 0.01% 1281
2019
Q2
$218K Sell
68,079
-82,598
-55% -$282K 0.02% 1193
2019
Q1
$618K Buy
150,677
+19,877
+15% +$126K 0.06% 561
2018
Q4
$828K Buy
+130,800
New +$1.36M 0.1% 302
2017
Q3
Sell
-43,541
Closed -$1.4M 1814
2017
Q2
$1.4M Buy
43,541
+23,572
+118% +$774K 0.09% 311
2017
Q1
$691K Buy
19,969
+10,278
+106% +$367K 0.04% 887
2016
Q4
$342K Sell
9,691
-21,727
-69% -$734K 0.02% 1253
2016
Q3
$1.09M Sell
31,418
-473
-1% -$16.6K 0.06% 565
2016
Q2
$1.19M Sell
31,891
-859
-3% -$32.3K 0.07% 523
2016
Q1
$1.32M Sell
32,750
-3,941
-11% -$147K 0.08% 392
2015
Q4
$1.32M Buy
+36,691
New +$1.33M 0.06% 500
2015
Q3
Sell
-27,591
Closed -$938K 1954
2015
Q2
$938K Sell
27,591
-26,654
-49% -$898K 0.04% 956
2015
Q1
$1.84M Buy
54,245
+12,854
+31% +$448K 0.07% 392
2014
Q4
$1.45M Buy
41,391
+10,965
+36% +$369K 0.1% 259
2014
Q3
$996K Buy
30,426
+5,306
+21% +$181K 0.05% 495
2014
Q2
$854K Buy
25,120
+3,478
+16% +$119K 0.04% 771
2014
Q1
$758K Sell
21,642
-18,793
-46% -$663K 0.05% 484
2013
Q4
$1.48M Buy
40,435
+4,200
+12% +$154K 0.12% 171
2013
Q3
$1.25M Buy
36,235
+10,014
+38% +$350K 0.1% 244
2013
Q2
$887K Buy
+26,221
New +$870K 0.11% 255

Other funds holding ACH

GSA Capital Partners's ACH Position: Q1 2024 in Review

GSA Capital Partners sold out of Accendra Health (ACH) in Q1 2024, closing a stake of 37,089 shares — an estimated $715K sold.

GSA Capital Partners first reported a position in ACH in Q2 2013 and held it in 24 quarters. The position peaked at $1.84M in Q1 2015. 231 funds tracked by Wall St. Rank hold ACH as of Q1 2024.

  • GSA Capital Partners reported no remaining Accendra Health position as of Q1 2024 after selling out during the quarter.
  • GSA Capital Partners sold 37,089 Accendra Health shares in Q1 2024, an estimated $715K.
  • GSA Capital Partners first reported a position in Accendra Health in Q2 2013 and held it in 24 quarters.
  • GSA Capital Partners's Accendra Health position peaked at $1.84M in Q1 2015.
  • 231 funds tracked by Wall St. Rank held Accendra Health as of Q1 2024.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.